Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial
Journal of Medical Internet Research · 2023
DOI: 10.2196/44939 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medical Internet Research, 2023. Verfasst von DuanBin Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atherosclerosis, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Elevated low-density lipoprotein cholesterol (LDL-C) is an established risk factor for atherosclerotic cardiovascular disease (ASCVD). However, low adherence to medication and lifestyle management has limited the benefits of lowering lipid levels. Cognitive behavioral therapy (CBT) has been proposed as a promising solution.
Objective
This trial aimed to evaluate the efficacy of mobile-based CBT interventions in lowering LDL-C levels in patients with ASCVD.
Methods
This multicenter, prospective, randomized controlled trial enrolled 300 patients with ASCVD, who were randomly assigned to the mobile-based CBT intervention group and the control group in a ratio of 1:1. The intervention group received CBT for ASCVD lifestyle interventions delivered by WeChat MiniApp: “CBT ASCVD.” The control group only received routine health education during each follow-up. The linear regression and logistic regression analyses were used to determine the effects of a mobile-based CBT intervention on LDL-C, triglyceride, C-reactive protein, the score of General Self-Efficacy Scale (GSE), quality of life index (QL-index), and LDL-C up-to-standard rate (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China.
- Ningbo First Hospital, Ningbo, China.
- Ningbo Ninth Hospital, Ningbo, China.
- Hangzhou Medical College Affiliated Lin An People's Hospital, Hangzhou, China.
- Linping Integrative Medicine Hospital, Hangzhou, China.
ORCID-Profile: DuanBin Li, Tian Xu, DaQi Xie, MiaoYun Wang, ShuPing Sun, Min Wang, SiSi Zhang, XinRui Yang, ZhongNan Zhang, Shen Wang, Ming Kuang, Jia Tang, HongYing Liu, XuLin Hong, GuoSheng Fu, WenBin Zhang
Zitieren
APA
Li, D., Xu, T., Xie, D., Wang, M., Sun, S., Wang, M., Zhang, S., Yang, X., Zhang, Z., Wang, S., Kuang, M., Tang, J., Liu, H., Hong, X., Fu, G., & Zhang, W. (2023). Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial. Journal of Medical Internet Research. https://doi.org/10.2196/44939
Vancouver
Li D, Xu T, Xie D, Wang M, Sun S, Wang M, et al. Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial. Journal of Medical Internet Research. 2023. doi:10.2196/44939
BibTeX
@article{Li2023,
author = {Li, DuanBin and Xu, Tian and Xie, DaQi and Wang, MiaoYun and Sun, ShuPing and Wang, Min and Zhang, SiSi and Yang, XinRui and Zhang, ZhongNan and Wang, Shen and Kuang, Ming and Tang, Jia and Liu, HongYing and Hong, XuLin and Fu, GuoSheng and Zhang, WenBin},
title = {Efficacy of Mobile-Based Cognitive Behavioral Therapy on Lowering Low-density Lipoprotein Cholesterol Levels in Patients With Atherosclerotic Cardiovascular Disease: Multicenter, Prospective Randomized Controlled Trial},
journal = {Journal of Medical Internet Research},
year = {2023},
doi = {10.2196/44939}
}
EUVIMED